Search for: "Teva Pharmaceuticals"
Results 701 - 720
of 1,424
Sorted by Relevance
|
Sort by Date
5 Oct 2011, 3:44 am
Highlights this week included: Angiomax (Bivalirudin) – Teva drops attempts to void Angiomax patents, but will supply Medicines Company with the active ingredient (The IP Factor) (GenericsWeb) US: Rep. [read post]
5 Oct 2011, 3:44 am
Highlights this week included: Angiomax (Bivalirudin) – Teva drops attempts to void Angiomax patents, but will supply Medicines Company with the active ingredient (The IP Factor) (GenericsWeb) US: Rep. [read post]
2 Dec 2009, 4:31 am
You can separately subscribe to the IP Think Tank Global Week in Review at the Subscribe page: http://duncanbucknell.com/subscribe/ Highlights this week included: World AIDS Day: Make it happen (Patent Baristas) (IP Watch) Venezuela to examine all pharmaceutical patents (IP tango) General World AIDS Day: Make it happen (Patent Baristas) (IP Watch) Biodiversity negotiations need to allow for flexibility in business, industry says (IP Watch) Brazilian government tailors a bill… [read post]
6 Apr 2016, 4:06 am
Reddy's and Teva (as extensively covered by Patently-O) interprets AIA prior art provisions to overrule the venerable Metalizing Engineering Co. v. [read post]
28 Aug 2009, 8:11 am
Teva Pharmaceuticals USA, Inc. [read post]
11 May 2023, 2:21 am
On 4 May 2023, a mere two weeks after the conclusion of the hearing, the Court of Appeal handed down its decision in Sandoz and Teva v BMS. [read post]
23 Jul 2018, 2:38 pm
Mylan Pharmaceuticals Inc., Teva Pharmaceuticals USA, Inc., AKORN, Inc. [read post]
26 Apr 2018, 4:48 am
This case concerned an SPC Gilead had obtained for the combination of tenofovir and emtricitabine based upon Gilead’s patent, which claimed “A pharmaceutical composition comprising a compound according to any one of claims 1 to 25 together with a pharmaceutically acceptable carrier and optionally other therapeutic ingredients”. [read post]
3 Oct 2022, 8:27 am
” Teva v. [read post]
30 Jul 2013, 2:53 pm
One such case is Generics [UK] Ltd (t/a Mylan) v Yeda Research And Development Co Ltd and Teva Pharmaceutical Industries Ltd [2013] EWCA Civ 925, decided yesterday by a three-man Court of Appeal for England and Wales which consisted of two specialist IP judges -- Lords Justices Kitchin and Floyd -- together with Lord Justice Moses. [read post]
24 Aug 2020, 12:00 am
In general, proceedings in the field of mechanical engineering will be classified as “regular” and proceedings in the field of pharmaceuticals as “complex”. [read post]
19 Feb 2024, 12:55 pm
Teva and Apotex, filed Abbreviated New Drug Applications (ANDAs) with the FDA seeking to market generic versions of the $100m+ drug. [read post]
21 Jul 2023, 4:47 pm
Teva Pharmaceuticals USA, Inc., No. 1:20-cv-11548 (D. [read post]
12 Oct 2010, 8:56 pm
Highlights this week included: Aricept(Donepezil) –US: Declaratory judgment jurisdiction for subsequent Paragraph IV filers: Teva Pharmaceuticals USA, Inc. v. [read post]
11 Jan 2013, 4:00 am
Pfizer 2012 SCC 60 (“Teva 2012”)). [read post]
9 Jan 2024, 6:17 am
Manufactured by Teva Pharmaceuticals, it has been available since the late 1980s. [read post]
9 Oct 2012, 6:31 am
The Food and Drug Administration took a highly unusual step this week: It acknowledged that a widely used generic drug -- a copycat of the antidepressant Wellbutrin XL -- was not the equivalent of the original drug produced by GlaxoSmithKline since 2003.The move prompted the world's largest manufacturer of generic drugs, Israel-based Teva Pharmaceuticals, to stop shipping its generic extended-release bupropion -- marketed as Budeprion… [read post]
2 Aug 2009, 8:33 pm
Teva Pharmaceuticals... [read post]
4 Dec 2018, 2:51 pm
Teva Pharmaceuticals USA, Inc., No. 17-1229. [read post]
2 Dec 2018, 9:00 am
Teva Pharmaceuticals USA Inc. [read post]
